
Natco Pharma Q2 FY27 Results: Consolidated Net Profit ₹203 Crore on Total Income of ₹1,019 Crore
Natco Pharma (NSE: NATCOPHARM) reported consolidated total income of ₹1,019 crore and net profit of ₹203 crore for the quarter ended 30 Sep 2026, it said in a filing on 13 Nov 2026. Standalone total income was ₹895 crore and standalone net profit ₹143 crore for the same quarter.
- Earnings
- Pharmaceuticals